Biogen Completes Separation of Global Hemophilia Business, Bioverativ

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. ROST
5. BILL
6. WMT
7. ADI
8. MRK
9. MRNA
10. LOW

Go back to Biogen Completes Separation of Global Hemophilia Business, Bioverativ
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 214.35 -7.21 (3.25%)
Previous Close $221.56    52 Week High $333.65 
Open $217.98    52 Week Low $223.02 
Day High $221.29    P/E 27.45 
Day Low $214.16    EPS $7.81 
Volume 808,387